Noninvasive monitoring of β-cell mass and fetal β-cell genesis in mice using bioluminescence imaging

Experimental Animals

Volumn 61, Issue 4, 2012, Pages 445-451

  Sekiguchi, Yukari ^a   Owada, Junya ^a   Oishi, Hisashi ^a   Katsumata, Tokio ^a   Ikeda, Kaori ^a   Kudo, Takashi ^a   Takahashi, Satoru ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

cell genesis; Bioluminescence imaging; Diabetes mellitus; MIP Luc VU

Indexed keywords

LUCIFERASE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BIOLUMINESCENCE; CELL LOSS; CELL MASS; CELL MATURATION; CELLULAR PARAMETERS; CONTROLLED STUDY; FEMALE; FETUS; FETUS (ANATOMY); GENE; GESTATIONAL AGE; LIPID DIET; MAFA GENE; MAFK GENE; MALE; MOLECULAR IMAGING; MOUSE; MOUSE MUTANT; NONHUMAN; PANCREAS ISLET BETA CELL; PROMOTER REGION; REPORTER GENE; SIGNAL DETECTION; TRANSGENIC MOUSE;

ANIMALS; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; GENES, REPORTER; HOMEODOMAIN PROTEINS; INSULIN-SECRETING CELLS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MAF TRANSCRIPTION FACTORS, LARGE; MAFK TRANSCRIPTION FACTOR; MALE; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; MOLECULAR IMAGING; PREGNANCY; SPECIFIC PATHOGEN-FREE ORGANISMS; STREPTOZOCIN; TRANS-ACTIVATORS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84864500003     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.61.445     Document Type: Article

References (23)

1. A rtner, I., Hang, Y., Mazur, M., Yamamoto, T., Guo, M., Lindner, J., Magnuson, M.A., and Stein, R. 2010. MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes 59: 2530-2539. [Medline] [CrossRef]
2. Bell, G.I. and Polonsky, K.S. 2001. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414: 788-791. [Medline] [CrossRef]
3. Brennand, K. and Melton, D. 2009. Slow and steady is the key to beta-cell replication. J. Cell. Mol. Med. 13: 472-487. [Medline] [CrossRef]
4. Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A., and Butler, P.C. 2003. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110. [Medline] [CrossRef]
5. C hen, H., Carlson, E.C., Pellet, L., Moritz, J.T., and Epstein, P.N. 2001. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 50: 2040-2046. [Medline] [CrossRef]
6. C hen, X., Larson, C.S., West, J., Zhang, X., and Kaufman, D.B. 2010. In vivo detection of extrapancreatic insulin gene expression in diabetic mice by bioluminescence imaging. PLoS ONE 5: e9397. [Medline] [CrossRef]
7. D or, Y., Brown, J., Martinez, O.I., and Melton, D.A. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41-46. [Medline] [CrossRef]
8. Fowler, M., Virostko, J., Chen, Z., Poffenberger, G., Radhika, A., Brissova, M., Shiota, M., Nicholson, W.E., Shi, Y., Hirshberg, B., Harlan, D.M., Jansen, E.D., and Powers, A.C. 2005. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 79: 768-776. [Medline] [CrossRef]
9. K ojima, H., Fujimiya, M., Matsumura, K., Nakahara, T., Hara, M., and Chan, L. 2004. Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc. Natl. Acad. Sci. U.S.A. 101: 2458-2463. [Medline] [CrossRef]
10. Lubag, A.J., De Leon-Rodriguez, L.M., Burgess, S.C., and Sherry, A.D. 2011. Noninvasive MRI of beta-cell function using a Zn2+-responsive contrast agent. Proc. Natl. Acad. Sci. U.S.A. 108: 18400-18405. [Medline] [CrossRef]
11. Meier, J.J. 2008. Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 51: 703-713. [Medline] [CrossRef]
12. Noso, S., Kataoka, K., Kawabata, Y., Babaya, N., Hiromine, Y., Yamaji, K., Fujisawa, T., Aramata, S., Kudo, T., Takahashi, S., and Ikegami, H. 2010. Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes. Diabetes 59: 2579-2587. [Medline] [CrossRef]
13. Park, S.Y. and Bell, G.I. 2009. Noninvasive monitoring of changes in pancreatic beta-cell mass by bioluminescent imaging in MIP-luc transgenic mice. Horm. Metab. Res. 41: 1-4. [Medline] [CrossRef]
14. Park, S.Y., Wang, X., Chen, Z., Powers, A.C., Magnuson, M.A., Head, W.S., Piston, D.W., and Bell, G.I. 2005. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly luciferase transgene. Genesis 43: 80-86. [Medline] [CrossRef]
15. Sander, M., Sussel, L., Conners, J., Scheel, D., Kalamaras, J., Dela Cruz, F., Schwitzgebel, V., Hayes-Jordan, A., and German, M. 2000. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127: 5533-5540. [Medline]
16. Sever, D., Eldor, R., Sadoun, G., Amior, L., Dubois, D., Boitard, C., Aflalo, C., and Melloul, D. 2011. Evaluation of impaired beta-cell function in nonobese-diabetic (NOD) mouse model using bioluminescence imaging. FASEB J. 25: 676-684. [Medline] [CrossRef]
17. Shimohata, H., Yoh, K., Fujita, A., Morito, N., Ojima, M., Tanaka, H., Hirayama, K., Kobayashi, M., Kudo, T., Yamagata, K., and Takahashi, S. 2009. MafA-deficient and beta cell-specific MafK-overexpressing hybrid transgenic mice develop human-like severe diabetic nephropathy. Biochem. Biophys. Res. Commun. 389: 235-240. [Medline] [CrossRef]
18. Shimohata, H., Yoh, K., Morito, N., Shimano, H., Kudo, T., and Takahashi, S. 2006. MafK overexpression in pancreatic beta-cells caused impairment of glucose-stimulated insulin secretion. Biochem. Biophys. Res. Commun. 346: 671-680. [Medline] [CrossRef]
19. Smith, S.J., Zhang, H., Clermont, A.O., Powers, A.C., Kaufman, D.B., Purchio, A.F., and West, D.B. 2006. In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. Mol. Imaging 5: 65-75. [Medline]
20. Souza, F., Simpson, N., Raffo, A., Saxena, C., Maffei, A., Hardy, M., Kilbourn, M., Goland, R., Leibel, R., Mann, J.J., Van Heertum, R., and Harris, P.E. 2006. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J. Clin. Invest. 116: 1506-1513. [Medline] [CrossRef]
21. Virostko, J., Radhika, A., Poffenberger, G., Chen, Z., Brissova, M., Gilchrist, J., Coleman, B., Gannon, M., Jansen, E.D., and Powers, A.C. 2010. Bioluminescence imaging in mouse models quantifies beta cell mass in the pancreas and after islet transplantation. Mol. Imaging Biol. 12: 42-53. [Medline] [CrossRef]
22. Yong, J., Rasooly, J., Dang, H., Lu, Y., Middleton, B., Zhang, Z., Hon, L., Namavari, M., Stout, D.B., Atkinson, M.A., Tian, J., Gambhir, S.S., and Kaufman, D.L. 2011. Multimodality imaging of beta-cells in mouse models of type 1 and 2 diabetes. Diabetes 60: 1383-1392. [Medline] [CrossRef]
23. Zhang, C., Moriguchi, T., Kajihara, M., Esaki, R., Harada, A., Shimohata, H., Oishi, H., Hamada, M., Morito, N., Hasegawa, K., Kudo, T., Engel, J.D., Yamamoto, M., and Takahashi, S. 2005. MafA is a key regulator of glucosestimulated insulin secretion. Mol. Cell. Biol. 25: 4969-4976. [Medline] [CrossRef]